In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide
- 1 June 2000
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 18 (6), 615-622
- https://doi.org/10.1038/76448
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) miceGene Therapy, 1998
- Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic musclesGene Therapy, 1998
- Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?Neuromuscular Disorders, 1997
- Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors FollowingIn VivoAdministrationHuman Gene Therapy, 1997
- Successive injections in MDX mice of myoblasts grown with bFGFNeuromuscular Disorders, 1996
- Characterization of genetic deletions in becker muscular dystrophy using monoclonal antibodies against a deletion‐prone region of dystrophinAmerican Journal of Medical Genetics, 1995
- Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injectionHuman Molecular Genetics, 1993
- Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscleFEBS Letters, 1993
- An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophyGenomics, 1992
- Human dystrophin expression in mdx mice after intramuscular injection of DNA constructsNature, 1991